ALIMENTARY PHARMACOLOGY & THERAPEUTICS, vol.18, no.1, pp.151-155, 2003 (SCI-Expanded)
Background: Metoclopramide, a central and peripheral dopamine type 2 receptor antagonist, has been used as an attractive and safer alternative to cisapride. However, cardiac side-effects have also been reported with this drug.